Important News
1. The Federal Reserve cut interest rates by 25 basis points, resuming its rate cuts.
2. Ministry of Finance: Stamp duty revenue from securities transactions increased by 81.7% year-on-year from January to August.
3. A-share year-to-date trading volume reached 280 trillion yuan, more than doubling year-on-year, with market activity remaining high.
4. Ministry of Commerce: A series of special documents will be issued to expand service consumption, including those on the high-quality development of the accommodation industry and the integrated development of railways and tourism.
Individual Stock News
1. CATL: Sodium-new passenger car power batteries will be mass-produced next year.
2. Tianpu Shares resumed trading on the 18th: A short-term surge of 185%, but acquisitions carry uncertainties.
3. *ST Nanzhi: Proposed transfer of assets and liabilities related to real estate development and leasing businesses for 1 yuan, constituting a major asset reorganization.
4. Joyson Electronics: During the period of unusual stock trading fluctuations, Joyson Group increased its holdings of the company's A shares by 700,000 shares. 5. Changchun High-Tech: Jinsai Pharmaceutical will obtain exclusive distribution rights for three products in mainland China.
6. Xinhan New Materials: The controlling shareholder and actual controller plans to reduce their holdings in the company by no more than 2%.
7. China Resources Sanjiu: Plans to invest no more than 10 billion yuan of its own capital in bank wealth management products.
8. Amperon: The company's revenue from force sensors for robots accounts for a very low proportion of its core business revenue.
9. Xingye Technology: Signed a strategic cooperation agreement with Suzhou Nengsda to jointly develop flexible electronic skin.
10. Kosen Technology: The company's folding screen hinge assembly business has a single customer, and revenue from this business accounted for only 2.1% of total revenue in the first half of the year.
11. Zhifei Bio: The innovative drug CA111 injection has been approved for clinical trials in overweight or obese adults.
12. Hengrui Medicine: The new marketing application for Ruikang Trastuzumab Injection for the treatment of breast cancer has been accepted and placed under priority review. 13. Longhorn Automotive: The company's backlog order value is based on customer sales forecasts; the actual order value is subject to uncertainty due to market fluctuations.
14. Dongshan Precision: The current tight supply situation in the optical chip market is unlikely to ease in the short term. Source Photonics will focus on meeting the 1.6T optical module demand from top global technology customers through 2027.
